William B White
William B White
Three separate randomized, double-blind, parallel-group, 12-week trials compared telmisartan with enalapril, lisinopril, and amlodipine for treating mild to moderate hypertension. Telmisartan 80 mg was associated with a significantly greate...
A chronotherapeutic approach to effective blood pressure management [0.03%]
血压的有效管理的Chronotherapy方法论研究
Peter A Meredith
Peter A Meredith
The major randomized trials in hypertension have unequivocally demonstrated the benefits of treatment. None of these trials have sought to address the issue of the potential superiority of 24-hour blood pressure control. However, there is a...
Clinical benefits of consistent reduction in the daily blood pressure of hypertensive patients [0.03%]
高血压患者每日血压持续降低的临床效益
Giuseppe Mancia
Giuseppe Mancia
Mean 24-hour blood pressure (BP) values are more closely associated with cardiovascular events and target organ damage than are clinic measurements, and therefore may be more useful for assessing drug efficacy. Clinically important informat...
Pierre Larochelle
Pierre Larochelle
Awareness of an increased incidence of cardiovascular events shortly after awakening has heightened interest in the chronopathology of cardiovascular diseases. Blood pressure varies according to cycles characterized by a reduction during sl...
Marvin Moser,George L Bakris,Henry Black
Marvin Moser
Following a symposium on hypertension sponsored by the National Heart, Lung, and Blood Institute in Chicago, IL on October 3, 2001, a panel was convened to discuss various aspects of hypertension treatment. Moderating the panel was Dr. Marv...
Adrenal hyperplasia [0.03%]
肾上腺增生
J Handler
J Handler
R R Townsend
R R Townsend
Thomas G Pickering
Thomas G Pickering
D A Sica
D A Sica
Controlled clinical trials in cardiovascular disease are the cornerstone for therapeutic advances in this field of medicine. Since the introduction of the concept of controlled clinical trials there has been substantial progress in the desi...
D A Sica,A D Struthers,W C Cushman et al.
D A Sica et al.
The pivotal role of potassium (K+) in cardiovascular disease and the importance of preserving potassium balance have become clinical hot points, particularly as relates to new and emerging cardioprotective and renoprotective therapies that ...